167 related articles for article (PubMed ID: 35454158)
1. Prognostic Value of
Shaalan AAM; Mokhtar SH; Ahmedah HT; Almars AI; Toraih EA; Ibrahiem AT; Fawzy MS; Salem MA
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454158
[TBL] [Abstract][Full Text] [Related]
2. Genotype Triad for
Ismail NM; Toraih EA; Almars AI; Al Ageeli E; Fawzy MS; Maher SA
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626352
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
4. Expression of long intergenic non-coding RNA, regulator of reprogramming, and its prognostic value in patients with glioblastoma.
Toraih EA; El-Wazir A; Hussein MH; Khashana MS; Matter A; Fawzy MS; Hosny S
Int J Biol Markers; 2019 Mar; 34(1):69-79. PubMed ID: 30852975
[TBL] [Abstract][Full Text] [Related]
5. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variation in DEAD-Box Helicase 20 as a Putative Marker of Recurrence in Propensity-Matched Colon Cancer Patients.
Hobani YH; Almars AI; Alelwani W; Toraih EA; Nemr NA; Shaalan AAM; Fawzy MS; Attallah SM
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011315
[TBL] [Abstract][Full Text] [Related]
7. Role of Long Noncoding RNA Regulator of Reprogramming in Colon Cancer Progression via Epidermal Growth Factor Receptor Signaling.
Chen Y; Yang L; Yin D; Feng X; Jie J; Yao D; Chen J
Technol Cancer Res Treat; 2022; 21():15330338221114707. PubMed ID: 35946134
[No Abstract] [Full Text] [Related]
8. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
9. PUNISHER rs12318065 C>A transversion: a putative somatic driver mutation for poor prognosis in colon cancer.
Shaheen S; Alshammari EM; Mokhtar SH; Alshanwani AR; Toraih EA; Ibrahiem AT; Fawzy MS; Maher SA
Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35670784
[TBL] [Abstract][Full Text] [Related]
10. Long intergenic non-coding RNA, regulator of reprogramming (LINC-ROR) over-expression predicts poor prognosis in renal cell carcinoma.
Fawzy MS; Toraih EA; El-Wazir A; Hosny MM; Badran DI; El Kelish A
Arch Med Sci; 2021; 17(4):1016-1027. PubMed ID: 34336029
[TBL] [Abstract][Full Text] [Related]
11. Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility.
Luo C; Cao J; Peng R; Guo Q; Ye H; Wang P; Wang K; Song C
Sci Rep; 2018 Mar; 8(1):4680. PubMed ID: 29549263
[TBL] [Abstract][Full Text] [Related]
12. A review on the importance of LINC-ROR in human disorders.
Ghafouri-Fard S; Pourtavakoli A; Hussen BM; Taheri M; Kiani A
Pathol Res Pract; 2023 Apr; 244():154420. PubMed ID: 36989849
[TBL] [Abstract][Full Text] [Related]
13. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
[TBL] [Abstract][Full Text] [Related]
14. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
[TBL] [Abstract][Full Text] [Related]
15. Linc-ROR genetic variants are associated with the advanced disease in oral squamous cell carcinoma.
Rose MM; Dhamodharan S; Bharath G; Murali K; Subbiah S; Bhaskar LV; Murugan AK; Munirajan AK
Arch Oral Biol; 2022 Jul; 139():105428. PubMed ID: 35461069
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.
Roth AD; Tejpar S; Delorenzi M; Yan P; Fiocca R; Klingbiel D; Dietrich D; Biesmans B; Bodoky G; Barone C; Aranda E; Nordlinger B; Cisar L; Labianca R; Cunningham D; Van Cutsem E; Bosman F
J Clin Oncol; 2010 Jan; 28(3):466-74. PubMed ID: 20008640
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
Arunkumar G; Deva Magendhra Rao AK; Manikandan M; Arun K; Vinothkumar V; Revathidevi S; Rajkumar KS; Rajaraman R; Munirajan AK
Tumour Biol; 2017 Apr; 39(4):1010428317698366. PubMed ID: 28443494
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of LINC-ROR in cancer cell lines and tissues.
Rezaei M; Emadi-Baygi M; Hoffmann MJ; Schulz WA; Nikpour P
Tumour Biol; 2016 Feb; 37(2):1763-9. PubMed ID: 26314857
[TBL] [Abstract][Full Text] [Related]
20. Migration/Differentiation-Associated LncRNA
Al Ageeli E; Attallah SM; Mohamed MH; Almars AI; Kattan SW; Toraih EA; Fawzy MS; Darwish MK
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
